Laboratoire ICARE has sold a minority stake to MBO Partenaires
Naxicap Partners has sold a minority stake in Laboratoire ICARE to MBO Partenaires. Financial details have not been disclosed.
Laboratoire ICARE is the leader in the French market for microbiological analysis in the health industry through sustained growth since its inception in 1995. The company is composed of a multidisciplinary team, highly skilled and distributed in eight support services and two divisions.
Founded in 2002 and wholly owned by its management team, MBO Partenaires is an independent private equity firm with an entrepreneurial mindset. MBO Partenaires has been supporting French SMEs in their growth projects for almost fifteen years, and more recently Spanish, Belgian and Swiss companies as well. With over one hundred transactions completed since its creation, MBO Partenaires has established itself as an involved and committed shareholder alongside the entrepreneurs, making it their leading partner.
Naxicap Partners has been a responsible and committed financial partner for companies for over 30 years, and is now one of the leading providers of equity financing for businesses in France.
Oaklins' team in France advised the seller in this transaction.
Talk to the deal team
Related deals
Valmiermuižas Alus has been acquired by Cēsu Alus
Valmiermuižas Alus has been acquired by Cēsu Alus AS through the purchase of 100% of its shares. The transaction enabled the founder’s exit and strengthened the company’s platform for continued growth within a consolidating Baltic beverage market.
Learn moreLindenhofgruppe has sold its majority stake in LabPoint to Affidea Switzerland
LabPoint Medical Laboratories AG has been acquired by Affidea Switzerland AG. Through the transaction, Lindenhofgruppe AG gains a strong strategic partner to support the further development of LabPoint and will remain a shareholder with a reduced stake, continuing as a key customer of the company. It lays the foundation for LabPoint’s sustainable development under a new anchor shareholder, with the aim of further strengthening and selectively expanding its position in laboratory diagnostics.
Learn moreArmira has signed an agreement to acquire a majority stake in Viabus
Armira, a Germany-based investment firm, has signed an agreement to acquire a majority stake in Viabus, a leading Dutch tour operator focused on senior and young senior travelers.
Learn more